146 research outputs found

    An exploration of stakeholders’ perceptions of the barriers to clinical use of Assistive Technologies in services for upper-limb stroke rehabilitation

    No full text
    Introduction Half of all patients commencing stroke rehabilitation have marked impairment of the hemiplegic arm, with only 14% regaining useful function. Assistive technologies (ATs) have been developed and evaluated yet currently reach only a fraction of patients. The NIHR funded a five year research programme to generate understanding necessary to develop cost-effective stroke services in upper-limb rehabilitation. This stage aims to understand the potential advantages and disadvantages to the clinical use of ATs, and the needs and priorities of stakeholders. Method Participants include people with a stroke (n=40), their carers (n=20), health care professionals (n= 40), budget holders (n=15) and service commissioners (n=15). An interactive exhibition was held at the University of Southampton in October 2009 where stakeholders tested a range of ATs. Focus groups with each stakeholder group will be conducted within three months of the exhibition to discuss personal involvement in AT use, and positive and negative views on the AT presented. Results Results will be categorised in terms of barriers and facilitators to the use of upper-limb technologies addressing issues such as user comfort and acceptability, cost-benefit, evidence of effect and funding provision. Conclusion Getting research implemented in practice is challenging. This novel approach explores the barriers to using new technologies from the perspective of all key stakeholders. These findings will be combined with those of a national survey, and systematic review to inform a clinical trial resulting in a recommended care pathway for upper-limb rehabilitation

    Assessment of fracture risk tools in care home residents: a multi-centre observational pilot study.

    Get PDF
    BACKGROUND: Fragility fractures are common in care home residents but established tools have not been tested in this population. AIM: To identify the most practicable tool for use. METHODS: DESIGN: Multicentre prospective observational cohort pilot study. SETTING: 18 care homes in Boston, UK. ASSESSMENTS: fragility risk score at baseline with FRAX, QFractureScore, Garvan nomogram, body mass index and TUGT for each participant. OUTCOMES: falls, fractures, combined falls & fractures. Follow-up; 12 months. RESULTS: 217/618 (35%) residents in the 18 care homes were enrolled. 147 (68%) had mental capacity,70 (32%) did not. There were 325 falls and 10 fractures in participants during the study. At the same time there were 1671 falls and 103 fractures in residents not participating in the study. Multiple regression analyses showed that only age had a statistically significant association with falls (χ2(1) = 5.7775, p = 0.0162), fractures (χ2(1) = 4.7269, p = 0.0297) and combined falls & fractures (χ2(1) = 4.7269, p = 0.0297). C-statistics were: falls; FRAX 0.544, BMI 0.610, QFractureScore 0.554, Garvan nomogram 0.579, TUGT 0.656, fractures; FRAX 0.655, BMI 0.708, QFractureScore 0.736, Garvan nomogram 0.712, TUGT 0.590, combined falls and fractures, c-statistics were same as for fractures. Fifty-four participants (25%) died during follow-up. Charlson comorbidity index predicted mortality, R2 = 0.021 (p = 0.034). CONCLUSIONS: QFractureScore, BMI and Garvan nomogram were good predictors of fractures and combined falls and fractures Only age had statistically significant association with the outcomes. No tool was good predictor of falls

    Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity: Secondary analysis of a randomised controlled trial.

    Get PDF
    OBJECTIVE: To estimate the cost-consequence of treating spasticity early with botulinum toxin in the acute stroke unit. DESIGN: Secondary cost-consequence analysis, using data from a double-blind randomised-controlled trial. SETTING: Single-centre specialised stroke unit. SUBJECTS AND INTERVENTIONS: Patients with Action Research Arm Test grasp-score of <2 and who developed spasticity within six weeks of a first stroke were randomised to receive injections of: 0.9% sodium-chloride solution (placebo) or onabotulinumtoxin-A (treatment). MAIN MEASURES: Resource use costs were calculated for the study. Mean contracture costs for each group were calculated. The Barthel Index and Action Research Arm Test were used to generate a cost per unit of improvement. RESULTS: There were no significant differences associated with early treatment use. The mean contracture cost for the treatment group was £817 and for the control group was £2298 (mean difference = -£1481.1(95% CI -£2893.5, -£68.7) (p = 0.04). The cost per unit of improvement for the Barthel Index was -£1240 indicating that the intervention costs less and is more effective. The cost per unit of improvement for the Action Research Arm Test was -£450 indicating that the intervention costs less and is more effective. CONCLUSIONS: Treating spasticity early in stroke patients at risk of contractures with botulinum toxin leads to a significant reduction in contracture costs. The cost per improvement of Barthel and Action Research Arm Test indicates that the intervention costs less and is more effective. TRIAL REGISTRATION DATA: EudraCT(2010-021257-39) and ClinicalTrials.gov-Identifier:NCT01882556

    Evaluating the Associations between Physical Activity, Weight Gain and Academic Attainment in Primary School Children

    Get PDF
    Objective: The aim of this study was to identify if there is an association between physical activity, body mass and academic attainment in primary school children.Methods: Eighty-six children at a UK primary school were included in this cohort analysis. Physical activity status was determined using the Physical Activity Questionnaire – Children. Weight and height was measured, and BMI calculated at 4-time points. Academic attainment was measured from national standardised tests.Results: Children who are less active demonstrated lower height (mean difference (MD) 0.49 95% CI 0.08 to 0.90), weight (MD 0.58 95% CI 0.12 to 1.04) and BMI z-scores (MD 0.48 95% CI -0.04 to 1.00) than children who are more active. They also had a higher rate of weight gain (0.06 z-score units/month), than children who are more active (0.05*z-core units/ month), and had greater fluctuations in weight. Children who were more active performed significantly better than children who are less active in writing (χ2 16.40, p=0.003) and mathematics (χ2 12.18, p=0.02).Conclusion: There does appear to be an association between physical activity, body mass and academic attainment in primary school children, such that lower activity levels negatively effects growth and academic performance. These differences could not be solely explained by physical activity level due to unaccounted socio-economic factor

    A Scoping Literature Review of Studies Assessing Effectiveness and Cost-Effectiveness of Prosthetic and Orthotic Interventions

    Get PDF
    Purpose: Approximately 1.5% of the world’s population (~100 million people) need a prosthesis/orthosis. The objective of the study was to establish an overview of the literature that has examined prosthetic and orthotic interventions with a view to inform policy development. Methods: Fourteen databases were searched from 1995-2015. Studies reporting primary research on the effectiveness or cost-effectiveness of prosthetic and orthotic interventions were examined. Metadata and information on study characteristics were extracted from the included studies. Results: The searches resulted in a total of 28,958 articles, a focus on studies with the words “randomised” OR “randomized” OR “cost” OR “economic” in their citation reduced this total to 2,644. Research has predominantly been conducted in Australia, Canada, Germany, Netherlands, UK and USA. 346 randomised controlled trials were identified, with only four randomised controlled trials examining prosthetic interventions. The majority of research examined lower limb orthoses in the adult population and used a wide range of outcome measures. Conclusions: While various international organisations have highlighted the value of providing prosthetic and orthotic services, both to the user and society as a whole, the availability of scientific research to inform policy is limited. Future structured evaluation of prosthetic and orthotic interventions/services is warranted to inform future policy developments

    Lower-limb neuromuscular electrical stimulation (NMES) for people with chronic kidney disease undergoing dialysis (Protocol)

    Get PDF
    This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of neuromuscular electrical stimulation (NMES) on muscle structure and function in people undergoing dialysis

    Quantifying Missingness in Wearable Heart Rate Recordings.

    Get PDF
    Wrist-worn photoplethysmography (PPG) heart rate monitoring devices are increasingly used in clinical applications despite the potential for data missingness and inaccuracy. This paper provides an analysis of the intermittency of experimental wearable data recordings. Devices recorded heart rate with gaps of 5 or more minutes 41.6% of the time and 15 or more minutes 3.8% of the time
    corecore